Full Year 2020 revenue increased 1,972% year-over-year to $39.9 millionQ4 2020 revenue increased 615% year-over-year to $10.5 millionEnded 2020 with over $45 million of cash after closing the first tranche of oversubscribed Regulation A, Tier 2, equity...
Trial designed to investigate the cardioprotective properties of CardiolRx™ in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease Oakville, ON – April 28, 2021 – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX:...
Fiore Gold - Firing on all cylinders as gold prices rise FIORE GOLD TSXV:F | OTC:FIOGF | FSE:2FO Following a dip from record highs hit last year, gold prices are once again on the rise. Indeed, the threat of rapid global inflation in the face...
The End of Gas Stations? CLEAN POWER CAPITAL CORP CSE:MOVE | OTC:MOTNF With one small move, this could signal the beginning of the end of gas stations as we know them today. And what replaces them could launch us into the next generation of transportation over the...
April 14, 2021 – Relay Medical Corp. (“Relay” or the “Company”) (CSE: RELA, OTC: RYMDF, Frankfurt: EIY2) and Fio Corporation (“Fio”) together through their joint venture company, Fionet Rapid Response Group (“FRR”), announce the execution of an agreement with...
Act now! The latest investment opportunity you won't want to miss is plant-based PLANT&CO BRAND CSE:VEGN | OTC:VGANF | FSE:VGP Now is the time to take notice of plant-based investment opportunities. The sector is thriving! And in this booming environment,...
RED WHITE & BLOOM BRANDS CSE:RWB | OTC:RWBYF Red White & Bloom’s core aim is as bold as it is simple... To become one of the top three MJ operators in the US. For a company that is still relativity small—and significantly undervalued compared to its...
As the founder of JW Asset Management—which is now estimated to oversee more than $2 billion of funds—Jason Wild has been quietly building a reputation as one of the shrewdest investors around. So, today, it’s very interesting to learn that he is reportedly...
Results expected to support the Company’s plans to file an IND application withthe FDA for a Phase II international trial in acute myocarditis Oakville, ON – April 12, 2021 – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) (“Cardiol” or the “Company”),...